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PEMBANGUNAN UJIAN AMPLIFIKASI ASID NUKLEIK BAGI TUJUAN 
PENGESANAN KUMAN MYCOBACTERIUM TUBERCULOSIS  
ABSTRAK 
 
Batuk kering ialah salah satu penyakit berjangkit yang lazim di Malaysia, yang 
disebabkan oleh patogen bawaan udara, Mycobacterium tuberculosis. Disebabkan sifat 
jangkitan penyakit ini, pengesanan diagnostik berasaskan M. tuberculosis adalah penting 
untuk pengurusan penyakit yang berkesan, pemantauan, kajian epidemiologi serta untuk 
pengurusan rawatan yang tepat dan cepat. Kaedah-kaedah diagnosis semasa bergantung 
kepada calitan mikroskop dan pengkulturan. Bagaimanapun kaedah-kaedah ini tidak 
spesifik atau mengambil masa yang lama. Ini menyebabkan perhatian diberikan terhadap 
kaedah pengesanan M. tuberculosis berdasarkan asid nukleik yang memerlukan sasaran 
asid nukleik yang sesuai dijadikan sebagai penanda diagnostik. Satu kelas asid nukleik, 
yang merupakan RNA-bukan-pengekodan-protein, ialah kelas RNA yang tidak 
diterjemahkan kepada protein tetapi memainkan peranan dalam melaksanakan fungsi 
pengawalseliaan tertentu. Ia juga menunjukkan potensi untuk dimanfaatkan sebagai 
penanda bio diagnostik. Analisis berasaskan bioinformatik mendedahkan kehadiran 140 
jujukan yang berpotensi sebagai penanda diagnostic. Salah satu daripada jujukan 
tersebut, npcTB 6715, khusus untuk M. tuberculosis dipilih sebagai penanda diagnostik 
yang berpotensi dan diuji. Sebagai ujian pengesanan berasaskan asid nukleik paling 
mantap, asai PCR dipilih sebagai strategi pilihan untuk menguji potensi npcRNA ini 
untuk pengesanan diagnostik M. tuberculosis. Multiplex PCR (mPCR) yang 
dibangunkan, menggabungkan gen IS6110 dengan npcTB 6715, di mana penggunaan 
xv 
 
npcRNA ini mampu mengesan M. tuberculosis yang tidak mempunyai gen IS6110, 
sekaligus mampu mengelakkan keputusan negatif palsu. mPCR ini menunjukkan had 
pengesanan sebanyak 10 pg. Evaluasi mPCR dengan 500 kultur Mycobacterium 
menunjukkan nilai-nilai 98.4%, 96.1%, 98.6% dan 95.4% masing-masing untuk 
kepekaan, kekhususan, Nilai Ramalan Positif dan Nilai Ramalan Negatif. Nilai-nilai 
yang diperolehi mencadangkan potensi diagnostik mPCR, sebagai ujian diagnostik 
untuk mengesan M. tuberculosis dan menyokong potensi diagnostik npcTB 6715. 
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DEVELOPMENT OF A NUCLEIC ACID AMPLIFICATION TEST FOR THE 
DETECTION OF MYCOBACTERIUM TUBERCULOSIS 
ABSTRACT 
 
Tuberculosis is one of the common infectious diseases in Malaysia, caused by 
the airborne pathogen, Mycobacterium tuberculosis. Due to the infectious nature of the 
disease, diagnostic-based detection of Mycobacterium tuberculosis is vital for effective 
disease management, surveillance, epidemiological purpose and for the administration of 
a prompt treatment. Current diagnostic methods rely on smear microscopy and culture 
method; however these strategies suffer from several pitfalls. This shifts the attention 
towards the nucleic-acid based detection of M. tuberculosis, which requires the 
identification of suitable nucleic acid target as the diagnostic marker. One novel class of 
nucleic acid, which is the non-protein-coding RNAs, is a class of RNA that is not 
translated into protein but perform certain regulatory functions, suggesting the 
potentiality to be harnessed as a diagnostic biomarker. Bioinformatic-based analysis 
revealed the presence of 140 npcRNA genes, one of it, npcTB 6715, which is specific 
for M. tuberculosis is chosen as the potential diagnostic marker. As the most established 
nucleic acid-based detection platform, PCR assay is chosen as the platform of choice to 
test the potentiality of this npcRNA for the diagnostic-based detection of                                    
M. tuberculosis. The PCR assay developed also incorporates IS6110 as the counterpart 
of npcTB 6715, whereby the usage of the npcRNA is able to detect the IS6110-deficient 
strains of M. tuberculosis, averting false-negative results. The multiplex PCR assay 
developed showed a detection limit of 10 pg. Evaluation with 500 Mycobacterium 
xvii 
 
cultures demonstrated values of 98.4%, 96.1%, 98.6% and 95.4%, respectively for the 
sensitivity, specificity, Positive Predictive Value and the Negative Predictive Value. The 
values obtained suggested the diagnostic potentiality of the mPCR, as a promising 
ASSURED’ diagnostic test for the specific detection of M. tuberculosis and 
corroborated the diagnostic potentiality of the npcTB 6715. 
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CHAPTER 1: 
INTRODUCTION 
 
1.1. Mycobacteria 
 
 Mycobacteria are aerobic, non-motile, non-sporulation rod shaped 
microorganisms, GC rich nucleotide containing microorganism with size range of 2-
4µm (length) and 0.5-0.2µm (wide). Classified under actinobacteria phylum, 
mycobacteria are further categorized into the family of Mycobacteriaceae. There are 
over a hundred species of Mycobacterium, which are genetically closely related as 
reported by16S rRNA sequencing studies (Tortoli, 2006). Generally, mycobacteria can 
be divided into three major categories (Figure 1.1): Mycobacterium tuberculosis 
complex (MTBC), non-tuberculosis mycobacteria (NTM) and Mycobacterium leprae 
(M. Leprae) (Jagielski et al., 2014).  
 
1.2 Non Tuberculous Mycobacteria (NTM) 
 
 NTM are ubiquitous in the environment. Most of the NTM are non-pathogenic 
organisms which are known to colonize water sources, soil, dust particles, and food 
supplies. NTM can be cultivated on common liquid and solid culture media. Depending 
on the growth period, they are divided into rapidly growing mycobacteria such as 
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Mycobacteria fortuitum, Mycobacteria chelonae, and Mycobacteria abscessus as well 
as slow growing species such as Mycobacteria avium, Mycobacteria kansasii, and 
Mycobacteria marinum. About 160 different species of NTM have been identified. 
 
1.3 M. leprae 
 
 One of the earliest identified slow growing NTM is the M. leprae. M. leprae 
causes leprosy (Hansen's disease) in human (Cole et al., 2001). M. leprae is an 
intracellular, pleomorphic and acid-fast bacterium. It is an aerobic bacillus (rod-shaped) 
surrounded by the characteristic waxy coating unique to mycobacteria. M. leprae is 
different from other mycobacteria in terms of the arrangement in smear, as it is 
arranged in parallel chains, just like cigarettes in a pack. Leprosy infections are mainly 
focused on the skin and peripheral nerves. Therefore, their diagnoses are largely 
established based on skin and neurologic examination of the patient. 
 
1.4 M. tuberculosis complex (MTBC) 
 
 MTBC is a group of closely related mycobacterial species consisting of                      
M. tuberculosis, M. bovis, M. africanum, M. microti, M. canetti, M. caprae, M. 
pinnipedii and M. mungi and M. suricattae. 
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 M. bovis, the main cause of TB in bovine animal is known to cause cross species 
infection from bovine to humans through consumption of contaminated milk (Cosivi et 
al., 1998). Originating from the African sub-continent, M. africanum represents another 
major cause of TB especially in Sub-Saharan Africa. However, reports on the presence 
of M. africanum have emerged in countries other than Sub-Saharan Africa such as 
England, Spain, and the United States (Desmond et al., 2004; Grange and Yates, 1989; 
Remacha Esteras et al., 2003). On the other hand, M. microtii is a rare pathogen that 
usually infects rodents and shrews (Cavanagh et al., 2002). M. canetti causes infection in 
humans although the prevalence of this subspecies in not common. Out of the many 
mycobacterial species of the MTBC, M. tuberculosis is the most common causative 
agent of TB among humans. 
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Figure 1.1 Phylogenetic lineage of Non-Tubercoulosis Mycobacteria, M. leprae and M. 
tuberculosis complex [Adapted from (Haning et al., 2014)].  
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1.5. Mycobacterium tuberculosis  
 
 M. tuberculosis is a non-motile, slender, straight, or slightly curved bacillus. It 
is an obligate aerobic organism; hence it can only survive in an oxygen-containing 
environment. M. tuberculosis bacilli are 2-4 micrometers in length and 0.2-0.5 µm in 
width. The generation time of M. tuberculosis, in synthetic medium or infected animals 
is approximately 24 hours (Ginsberg and Spigelman, 2007). The slow growing feature 
of M. tuberculosis contributes to the chronic nature of the disease, which requires a 
prolonged treatment. In addition, the compositional complexity of its cell wall could 
also account for the nature of the disease, which represents a formidable impediment 
for researchers and health care system.  
 
1.5.1. Cell wall of M. tuberculosis confers pathogenesis and acid fast property 
 
 The cell wall of M. tuberculosis, is composed of peptidoglycan, arabinogalactan 
and mycolic acids covalently linked to each other (Figure 1.2) (Chatterjee, 1997). Due 
to the presence of mycolic acids, the primary stain used for gram staining does not 
penetrate well into the cell wall, making it unsuitable for gram staining (Washington, 
1996). As an alternative, acid-fast staining can be used to stain M. tuberculosis. The 
stain forms a complex with the mycolic acids, thereby resist decolorization by acid 
containing decolorization agent (Cheesbrough, 2006). These mycolic acids are also 
responsible for the pathogenesis of TB (Forrellad et al., 2013). 
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Figure 1.2: Mycobacterial cell wall [Reproduced from (Medjahed et al., 2010)]. 
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1.5.2  Transmission and immune response upon TB infection 
 
 TB infection spreads via droplets in the air expelled by an infected person during 
common daily acts such as sneezing, coughing, laughing, and even talking. The amount 
of bacilli present in the droplet, UV light exposure, ventilation factor and aerosolization 
occurrence plays important role in transmission (American Thoracic Society and CDC, 
2000). The spread of TB is enhanced by factors such as rapid increase in global travel, 
malnutrition, overcrowding, and co-infection of HIV and TB.  
 
 TB infection is a tug-of-war between the host immune system and the 
pathogen’s virulence. The first mechanism triggered upon the infection is the physical 
defense mechanism, which sets to expel any foreign molecules from invading the 
human body. Likewise, when a person inhales droplets containing M. tuberculosis 
bacilli, they are trapped in the upper respiratory. Following this, the mucus secreting 
Goblet cells on the respiratory tract would secrets mucus, trapping the pathogen and 
pushing it upwards to be expelled from the system. However, in some cases, the M. 
tuberculosis bacilli that managed to elude this physical defense system travels to the 
alveoli in the lungs and is predisposed to another mechanism known as the innate 
immune system. In this defense system, alveolar macrophage surrounds and phagocytes 
the M. tuberculosis, attempting to destroy the bacilli.  
 
 At this stage, destruction of the bacilli is reliant on the interplay between 
immunity of the host and the virulence of the bacilli itself (van Crevel et al., 2002). As 
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such, in immuno-compromised individual, viable M. tuberculosis that infects lungs 
cause pulmonary tuberculosis. The classic clinical symptoms of TB is productive cough 
that produces thick cloudy sputum for more than 2 weeks, chest pain, shortness of 
breath, hemoptysis, fever, chills, night sweats, loss of appetite and sudden weight loss. 
Apart from residing in the alveolus, viable M. tuberculosis can also travel to other 
tissue via the lymphatic system causing extrapulmonary TB (Dale et al., 2003). In 
addition, the infected individual also has the potential to incur infection on other 
individuals. In contrast, in the case of Latent TB, the infected person is not responsible 
for any transmission of TB. Only 5-10% of latent TB infection would develop into 
active TB. 
 
1.5.3 Epidemiology of Tuberculosis  
 
World Health Organization (WHO) estimated that 8.6 million people were newly 
infected by TB and 1.3 million deaths occurred due to TB infection in 2012 (WHO, 
2013).  Out of the 8.6 million TB cases, 2.9 million cases were women and 0.5 million 
cases occurred among children. Over 400000 deaths and 74000 deaths were women and 
children, respectively. Nearly 1 million deaths and 0.3 million deaths occurred among 
non-HIV infected individuals and HIV infected individuals, respectively. Global 
surveillance data indicated that most of the cases in 2012 occurred in Asia (58%) and 
the African region (27%) [Figure 1.3(A)]. Additionally, 22 countries around the world 
have been identified as 'High Burden' for TB and among them are the Asian countries 
such as India, China, Indonesia, Thailand, Bangladesh, and Vietnam.  
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 In Malaysia, according to the Ministry of Health Malaysia (MOHM), TB is one 
of the major 5 communicable diseases for the past 15 years (MOHM, 1997-2013). TB 
cases in Malaysia have steadily increased since 2005 and tend to rise further. In 2012, 
TB incidence rate including among HIV infected individuals was estimated at 24000 
(MOH, 2012). Mortality rates have been between 4 and 6% during the years from 1990 
to 2011 [Figure 1.3(B)]. Approximately 1414 deaths were reported and occurred among 
non-HIV infected individuals in 2012, with a mortality rate of 4.9% (WHO, 2014). Due 
to this alarming rate of TB infection, MOHM aims to strengthen the case detection and 
provide prompt treatment to TB infected individuals in Malaysia. In line with this, The 
National TB Control Program is currently implementing 'National Strategic Plan to 
Control TB, 2011-2015' to enhance all activities to reduce the burden of TB in the 
country (MOH, 2012). An effective diagnostic method for efficient management of the 
disease is also part of the endeavor to alleviate the problem of TB in the country. 
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(A) 
 
 
(B) 
 
 
Figure 1.3 (A): Estimated new TB rates for year 2012 (Adapted from Global 
tuberculosis Report 2013) (B): TB Mortality Rate in Malaysia, 1990-2012 (Adapted 
from Ministry of Health Malaysia Annual Report 2012). 
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1.6 Diagnostic of Tuberculosis 
 
 The very first step towards controlling TB infection is the suitable diagnostic 
method. This added with the infectious nature of TB, particularly which of the 
pulmonary TB, stresses the need for a fast and accurate diagnostic strategy. To date, a 
potpourri of diagnostic methods were devised, ranging from simple microscopy 
examination to intricate molecular methods. These methods vary in terms of duration, 
sensitivity, simplicity, or even specificity.  
 
1.6.1 Smear Microscopy 
 
 Smear microscopy represents the most common method for TB diagnosis. The 
microscopy method is easy, rapid, in-expensive and could identify individuals with TB 
at the infectious stage (Aber et al., 1980, Huebner et al., 1993). Due to the low cost, 
most low and middle-income countries utilize smear microscopy with Ziehl-Neelsen 
(ZN) staining as the primary tool to diagnose TB (Eyangoh et al., 2008). Samples, 
commonly sputum, were smeared directly on the slides without prior processing and are 
subjected to ZN staining. The acid-fast bacteria mycobacteria appear bright red with 
blue background following ZN staining [Figure1.4 (A)]. WHO has recommended 2 or 3 
sputum samples collected for laboratory examination (WHO, 1998).  
 
 Investigation of Acid Fast Bacilli (AFB) yield in serial sputum examination 
reported that 85.8% of TB cases were detected in the first sputum sample while an 
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increment of 11.9% and 3.1% were reported consecutively for the second and third 
samples (WHO, 2009). However, the shortcoming of smear microscopy is that it has 
low sensitivity and specificity; whereby the detection is limited only to 10,000 bacilli in 
1 mL of sample. This hampers diagnosis, especially for HIV-associated TB cases and 
among children who are unable to provide quality sputum samples. Furthermore, the 
presence of M. tuberculosis cannot be confirmed with smear microscopy alone.  
 
 The disadvantages associated with conventional compound microscope can be 
possibly addressed by the usage of Flourescence Microscopy (WHO, 2011). This 
microscope method relies on acid-fast fluorochrome stain such as auromine O or 
auramine-rhodamine instead of normal acid fast stain. Image visualization is actualized 
via powerful light source such as halogen, high presure mercury vapour lamp or Light-
emitting Diod (LED). Mycobacterium fluoresces against dark back ground as shown in 
Figure1.4 (B). FM increases sputum positive detection by 10 to 37% (Annam et al., 
2009, Hooja et al., 2011, Laifangbam et al., 2009). The application of FM consumes 
lesser time than conventional microscopy, as the former uses lower power objective 
lense (usually 25x) than that of the latter (usually 100x) (Kivihya-Ndugga et al., 2003; 
Steingart et al., 2006). Furthermore, florochrome staining method is relatively easier 
than Ziehl-Neelsen method (Holst et al., 1959). Although FM clearly has advantages 
over conventional microscopy, its use is limited by the high cost and it requires skillful 
personnel. Moreover, cases such as incorporation of florochrome dye into the inorganic 
objects and the ability of the dead cells to be stained with florochrome stain result in 
false positivity (Steingart et al., 2006; Washington, 2006). 
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(A) 
 
 (B) 
 
 
Figure 1.4: (A) Ziehl-Neelsen Stain (B) Auramine-rhodamine stain. The acid-fast 
bacteria mycobacteria appear bright red following Ziehl-Neelsen staining whereas in 
Auramine-Rhodamine staining the bacillus appears in orange colors (extracted on 15 
December 2014 from www below). 
http://www.digitalpathology.uct.ac.za/topics/classiccasesoftb/post_pulmonarytb.html). 
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1.6.2 Culture method 
 
 Culture method is considered as the ‘gold-standard’ for TB diagnostic. Firstly, 
sputum samples, are decontaminated and concentrated to maximize the recovery of M. 
tuberculosis. The digestion and decontamination method recommended by WHO is the 
Modified Petroff method (WHO, 1998). Finally, the decontaminated sample will be 
concentrated by centrifugation prior to the inoculation of the sediment into the culturing 
media. Cultivation of the M. tuberculosis requires egg-enriched media containing 
glycerol, asparagine and agar or liquid medium supplemented with serum or bovine 
albumin to grow (WHO, 1998). Most commonly used solid culture media to cultivate 
M. tuberculosis is Lowenstein-Jensen (Rageade et al., 2014). However, due to the slow-
growing nature of M. tuberculosis; the conventional culture method takes a period of 6-
8 weeks prior to the reporting of the result. Figure 1.5 (A) and (B) shows M. 
tuberculosis colonies grown on Lowenstein-Jensen media.  
 
 The slow-growing property that results in the delay of reporting M. tuberculosis 
cases can be possibly addressed with liquid culture using radiometric medium. The 
commercial liquid culture (Mycobacterium Growth Indicator Tube (MGIT), developed 
by Benton Dickinson, USA, was endorsed by WHO in 2007 (Boehme et al., 2013). 
Studies have reported that MGIT culture extensively reduces the time of detection to as 
low as 5 to 12 days and increases recovery chances of mycobacteria from clinical 
sample from 10 to 15%. The liquid culture system reportedly reduces number of false 
negativityby 50% (Chan et al., 2008; Hillemann et al., 2006; Satti et al., 2010). 
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However, contamination, cost and complexity of liquid culture system hinders its usage 
especially in low income countries (Boehme et al., 2013).  
 
 
 
Figure 1.5: (A) M. tuberculosis colony is buff to yellow in colour with rough and 
wrinkle appearance, (B) M. tuberculosis colony on Lowenstein-Jensen media, which 
takes 2-6 weeks to get visual colony growth (extracted on 15 Dec 2014 from www 
below).  
http://www.microbeworld.org/component/jlibrary/?view=article&id=6641 
(A)                                                       (B) 
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1.6.3 Nucleic acid-based detection of M. tuberculosis 
 
 The caveats associated with microscopy and culture method, which is time-
consuming and non-specific draws the attention towards the direct detection of M. 
tuberculosis sample. In tandem with this, Nucleic Acid Amplification Tests (NAAT) 
are harnessed as the diagnostic tool for the direct detection of M. tuberculosis. NAAT 
provides faster, more accurate results compared to the conventional biochemical based 
tests, allowing timely identification of active TB. Generally, NAAT is carried out in 
several steps. Firstly, the sample containing M. tuberculosis cells are lysed and the 
lysed samples are further processed to remove proteins or other unwanted compounds. 
Subsequently, specific nucleic acid sequences of M. tuberculosis are amplified to 
expedite detection by fluorescence or lateral flow assay (Boehme et al., 2013). The 
most common nucleic acid amplification method is the Polymerase Chain Reaction 
(PCR). 
 
1.7 Polymerase chain reaction (PCR) 
 
 Polymerase chain reaction (PCR) is a method first conceived in the 1980’s by 
Kary Mullis. PCR is used extensively in the field of molecular biology due to its 
specificity. The aim of PCR is to exponentially synthesize a predeterminated DNA 
sequence in vitro by using short oligonucleotides (termed primers). The first step in 
PCR is the denaturation process, whereby the reaction mixture containing DNA 
templates are heated at high temperature (90-95oC) for 30 sec to 5 min. This is followed 
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by the annealing step, the process at which both the forward and reverse primers anneal 
to their complementary sequences on the template DNA under the temperature between 
40-60oC. Next, is the elongation step, by which the temperature is raised to 72oC to 
allow the enzyme Taq Polymerase to carry out synthesis of new copies of sequences in 
the presence of magnesium ion, and excess amounts of dNTPs. This amplification, 
which occurs exponentially, allows easy detection of the amplicon, for example by 
visualization after running PCR product on the gel electrophoresis. The most important 
criterion prior to the development of a PCR assay is the identification of the suitable 
target for amplification. 
 
1.7.1 Non-protein coding RNAs (npcRNA) -Potential Diagnostic marker of PCR-
based detection of M. tuberculosis 
 
 Non-protein coding RNAs (npcRNA) are RNA transcripts capable of 
performing specific functions but are not translated into protein. One cut off size-based 
subgroup of npcRNAs, small RNAs, having the size range between 20-300 nts, 
participate in various cellular processes; housekeeping, virulence, pathogenesis, 
regulation of DNA replication, transcription, and mRNA stability (Bartel, 2004; 
Huttenhofer et al., 2005). To date, a large number of sRNA were identified and 
characterized (Gopinath et al., 2010; Storz, 2002, Washietl et al., 2005; Yong et al., 
2013; Zhou and Xie, 2011). Moreover, some of these molecules have been suggested as 
molecular markers of genetic diseases and cancer (Calin et al., 2004; Costa, 2005; 
Esteller, 2011; Hall and Russell, 2005; Meng et al., 2013; Ren et al., 2013; 
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Rozhdestvensky et al., 2007, Tang et al., 2005). One example is the MALAT1 sRNA 
that is reported as markers to determine the overall survival of patients (Zheng et al., 
2014). 
 
 On the other hand, infectious agents such as Helicobacter pylori (Sharma et al., 
2010) and Vibrio cholera (Livny and Waldor, 2010; Raabe et al., 2011) have been the 
subjects of immense interest towards the discovery of sRNAs. Previous studies carried 
out by our group have led to the discovery of 97 sRNAs from the human pathogen 
Salmonella Typhi, a causative agent of salmonellosis (Chinni et al., 2010). Recent study 
by Nithya et al., (2015) also have demonstrated the potentiality of the sRNA genes as 
the diagnostic marker for the differentiation of Salmonella species. Despite the growing 
evidence that sRNAs can serve as biological markers for human diseases, investigation 
into the use of small sRNAs as targets for the diagnosis of infectious agents has not 
been explored exhaustively. 
 
1.7.2 IS6110, the widely employed gene target for PCR-based detection of                        
M. tuberculosis 
 
 Amongst the available gene targets, IS6110, remains the most popular target for 
laboratory-developed tests against M. tuberculosis (Balamurugan et al., 2006; Chaidir 
et al., 2012; Deshpande et al., 2007; Maurya et al., 2011; Mokrousov et al., 2006; 
Mokrousov et al., 2003; Nandagopal et al., 2010). IS elements are segments of DNA 
that can insert at multiple sites in a target molecule (Mahillon and Chandler, 1998). In 
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M. tuberculosis, one particular IS element, IS6110 with the length of 1.36 kbp has 28-
bp terminal inverted repeats (TIR) at its ends (Figure 1.6). IS6110 is associated with the 
adaptation to the host, activation of genes during infection, evolution and is involved in 
activation of downstream genes with an orientation-dependent activity promoter 
(Alonso et al., 2013). IS6110 is present in multiple copies usually up to 6-25 times 
copies in the M. tuberculosis genome incontras with M. bovis, which contains only one 
copy (Philipp, 1996).  
 
 Its high specificity to MTBC, the presence in multiple copies and stability in the 
genome of M. tuberculosis renders IS6110 an ideal biomarker. Moreover location of an 
IS6110 copy in a specific strain can be used for rapid identification and the 
differentiation of that particular strain amidst the other strains (Millan-Lou et al., 2012). 
IS6110 has been extensively used in diagnostic and epidemiology study of M. 
tuberculosis. de Lassence and colleagues stipulated that the utilization of IS6110 in 
PCR is more sensitive than other identification protocol (de Lassence et al., 1992). 
Other studies, utilizes IS6110 gene detecting in M. tuberculosis with various success 
rates (Barani et al., 2011, Chaidir et al., 2012; Kulkarni et al., 2012). However, absence 
or low copy of IS6110 in certain strains of M. tuberculosis suggests that an additional 
target(s) could be amalgamated with IS6110 to elevate the efficiency and accuracy of 
the PCR-based diagnostic assay.  
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Figure 1.6: Diagram of IS6110. Diagram illustrates the position of the Terminal 
Inverted Repeats (TIR) and the two open reading frames orfA and orfB; two partially 
overlapping reading frames [Reproduced from (McEvoy et al., 2007)]. 
 
  
   IS6110 
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1.8. Research objectives 
 
 In concert with the effort to test the potentiality of the npcRNA genes as the 
potential diagnostic markers for M. tuberculosis detection, the incorporation of IS6110 
as the counterpart in PCR amplification is viewed to be able to ward off false negative 
results derived from IS6110-deficient M. tuberculosis strains. 
 
 Thus, the initial aim of the project was to identify npcRNA genes that could act 
as the potential diagnostic markers for M. tuberculosis detection. The identified target is 
then coupled with IS6110 towards the development and optimization of multiplex PCR. 
Collectively, the objectives are as follows; 
 
1. Identification of npcRNA genes specific for the detection of M. tuberculosis via 
BLASTn analysis Software. 
2. Development and optimization of the multiplex PCR using the identified 
npcRNA genes and IS6110 as the targets. The parameters are:- 
i) Optimization of annealing temperature 
ii) Optimization of primer concentration  
iii) Incorporation of Internal Amplification Control 
iv) Optimization of deoxyribonucleotide triphosphate 
v) Optimization of MgCl2 
vi) Determination of the specificity of mPCR 
vii) Determination of the sensitivity of the mPCR 
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3. Evaluation of the mPCR assay 
i) Validation of the developed mPCR with culture positive samples
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Materials  
2.1.1 Chemicals  
Chemicals and reagents used in this study were of analytical grade and are listed below: 
 
Manufacturer  Chemicals   
Amresco (USA) 
 
Bio basic inc (Canada) 
Bio-Rad (Hercules,USA) 
 
Biotools (Canada) 
 
 
Laborotarious Conda (Madrid,Spain) 
Merck (Darmstadt,Germany) 
 
 
 
Invitrogen ® (Carlsbad,CA) 
Promega (Madison,USA) 
 
Sodium acetate; Sodium hydroxide; 
Potassium chloride anhydrous. 
EDTA; PCR primers. 
Ethidium bromide (10mg/mL);  
Sodium deodecyl sulfate (SDS) 
10X PCR buffer; Magnesium 
chloride (MgCl2) ; dNTP mix; DNA 
polymerase. 
LB agar (lennox); LB broth (lennox), 
Middlebrooke 7H9, Middlebrooke 
7H10 
Ethanol; Acetic acid (glacial) 100%; 
Sodium hydroxide; Glycerol 
Ultra-pure Tris 
100bp DNA ladder; Agarose powder 
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2.1.2 Culture and bacterial strains 
 
 Bacterial strains used in this study are from the stock collection, obtained from 
the Department of Microbiology & Parasitology, School of Medical Sciences, USM 
and Infectomic Cluster, Advance Medical and Dental Institute (AMDI), USM. 
 
Bacterial Strains Description Source 
Mycobacterium 
tuberculosis H37Rv 
Virulent laboratory strain AMDI 
Mycobacterium 
tuberculosis H37Ra 
Attenuated tubercle bacillus closely 
related M. tuberculosis H37Rv 
AMDI 
Mycobacterium avium  Non tuberculosis Mycobacterium AMDI 
Mycobacterium 
abscessus 
Non tuberculosis Mycobacterium AMDI 
Mycobacterium 
fortuitum 
Non tuberculosis Mycobacterium AMDI 
Mycobacterium 
fortuitum 
Non tuberculosis Mycobacterium AMDI 
Mycobacterium 
gordonae 
Non tuberculosis Mycobacterium AMDI 
Mycobacterium 
scroferaceum 
Non tuberculosis Mycobacterium AMDI 
Mycobacterium 
intracellulare 
Non tuberculosis Mycobacterium AMDI 
Mycobacterium 
kansasii 
 
Non tuberculosis Mycobacterium AMDI 
